Beacon Capital Management LLC (Tennessee)’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.4K Hold
32,000
0.01% 174
2026
Q1
$77.1K Buy
32,000
+10,000
+45% +$22.3K 0.01% 165
2025
Q4
$44K Hold
22,000
0.01% 157
2025
Q3
$67.1K Buy
22,000
+6,000
+38% +$18.7K 0.01% 137
2025
Q2
$40.3K Buy
16,000
+10,000
+167% +$23.9K 0.01% 381
2025
Q1
$9.06K Hold
6,000
﹤0.01% 646
2024
Q4
$6.72K Hold
6,000
﹤0.01% 668
2024
Q3
$5.36K Hold
6,000
﹤0.01% 798
2024
Q2
$6.12K Hold
6,000
﹤0.01% 663
2024
Q1
$7.38K Hold
6,000
﹤0.01% 632
2023
Q4
$8.34K Hold
6,000
﹤0.01% 567
2023
Q3
$16.3K Hold
6,000
﹤0.01% 447
2023
Q2
$16.3K Buy
+6,000
New +$12K ﹤0.01% 447

Other funds holding MBOT

Beacon Capital Management LLC (Tennessee)'s MBOT Position: Q2 2026 in Review

Beacon Capital Management LLC (Tennessee) held its Microbot Medical (MBOT) position steady in Q2 2026 at 32,000 shares worth $62.4K. The position accounts for 0.01% of the portfolio, ranked #174.

Beacon Capital Management LLC (Tennessee) first reported a position in MBOT in Q2 2023 and has held it in 13 quarters since. The position peaked at $77.1K in Q1 2026. 19 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Beacon Capital Management LLC (Tennessee) held 32,000 shares of Microbot Medical worth $62.4K as of Q2 2026.
  • Beacon Capital Management LLC (Tennessee) left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up 0.01% of Beacon Capital Management LLC (Tennessee)'s portfolio in Q2 2026, its #174 holding.
  • Beacon Capital Management LLC (Tennessee) first reported a position in Microbot Medical in Q2 2023 and has held it in 13 quarters since.
  • Beacon Capital Management LLC (Tennessee)'s Microbot Medical position peaked at $77.1K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Beacon Capital Management LLC (Tennessee)'s 13F filing for Q2 2026, filed 29 Jul 2026.